Abstract

Septic shock represents a subset of sepsis with severe physiological aberrations and a higher mortality rate than sepsis alone. Currently, the laboratory tools which can be used to identify the state of septic shock are limited. In pre-clinical studies, extracellular vesicles (EVs), especially large EVs (lEVs), have been demonstrated a role as functional inflammatory mediators of sepsis. However, its longitudinal trend during the disease course has not been explored. In this study, the quantities and subtypes of plasma-derived lEVs were longitudinally compared between patients with septic shock (n = 21) and non-sepsis infection (n = 9), who presented within 48 h of their symptom onset. Blood specimens were collected for seven consecutive days after hospital admission. lEVs quantification and subtyping were performed using an imaging flow cytometer. The experiments revealed a higher lEVs concentration in septic shock patients than infected patients at the onset of the disease. In septic shock patients, lEVs concentration decreased over time as opposed to infected patients whose lEVs concentration is relatively static throughout the study period. The major contributors of lEVs in both septic shock and infected patients were of non-leukocyte origins; platelets, erythrocytes, and endothelial cells released approximately 40, 25, and 15% of lEVs, respectively. Among lEVs of leukocyte origins, neutrophils produced the highest number of EVs. Nevertheless, the proportion of each subtype of lEVs among the given amount of lEVs produced was similar between septic shock and infected patients. These findings raise the possibility of employing lEVs enumeration as a septic shock identifying tool, although larger studies with a more diverse group of participants are warranted to extrapolate the findings to a general population.

Highlights

  • WHO recognizes sepsis as a global health priority [1]

  • Similar to the trend we found on extracellular particles, on admission, a larger amount of large EVs (lEVs) were retrieved from the plasma of patients with septic shock compared to infected patients without sepsis (Figure 4A)

  • The difference in the number of lEVs between septic shock and infected patients was most prominent at the onset of the disease and gradually reduced as the patients progress through their clinical course

Read more

Summary

Introduction

Sepsis and septic shock are clinical syndromes defined as lifethreatening organ dysfunction caused by dysregulated host immune response to infection; infection per se may not cause sepsis [2, 3]. Systemic activation of various immune cells underlies the mechanisms in the pathogenesis of sepsis and septic shock; these cells produce an excessive amount of inflammatory mediators that induce endothelial injuries, coagulation abnormalities, and cellular damage, leading to endorgan dysfunction [4, 5]. Extracellular vesicles (EVs), heterogeneous membrane-bound vesicles released by various types of normal or diseased cells into the circulating system, is one of the mediators released by inflammatory cells in response to sepsis and septic shock [6]. The cross-sectional nature of previous studies omits the dynamicity of sepsis; their results may not be able to apply to patients presenting at different time points during the disease course

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call